Mark Gillies Selected Research

Cushing Syndrome

3/2013

Central serous chorioretinopathy: a review of epidemiology and pathophysiology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Gillies Research Topics

Disease

24	Blindness (Hysterical Blindness) 04/2024 - 01/2019
17	Macular Degeneration (Age-Related Maculopathy) 01/2024 - 02/2003
8	Macular Edema 04/2024 - 01/2010
7	Retinal Vein Occlusion 01/2023 - 06/2010
6	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 03/2008
5	Telangiectasis (Telangiectasia) 10/2019 - 12/2010
4	Polypoidal Choroidal Vasculopathy 11/2023 - 03/2013
4	Retinal Diseases 11/2022 - 01/2015
3	Atrophy 06/2023 - 01/2020
3	Cataract (Cataracts) 04/2022 - 12/2011
3	Choroidal Neovascularization 02/2022 - 03/2013
3	Vision Disorders (Hemeralopia) 01/2022 - 04/2005
3	Retinal Degeneration 01/2019 - 01/2015
2	Retinal Detachment (Retinal Detachments) 11/2022 - 04/2005
2	Fibrosis (Cirrhosis) 11/2021 - 12/2020
2	Ganglion Cysts (Ganglion) 10/2020 - 01/2018
2	Glaucoma 01/2020 - 09/2015
1	Type 2 Diabetes Mellitus (MODY) 01/2024
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2019
1	Multiple Sclerosis 01/2019
1	Neuromyelitis Optica (Devic's Disease) 01/2019
1	Retinoblastoma (Glioblastoma, Retinal) 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Retinal Neovascularization 01/2016
1	Infections 09/2015
1	Neuroinflammatory Diseases 01/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2013
1	Central Serous Chorioretinopathy 03/2013
1	Cushing Syndrome 03/2013
1	Diabetes Mellitus 05/2012

Drug/Important Bio-Agent (IBA)

35	Retinaldehyde (Retinal)IBA 04/2024 - 02/2003
19	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2024 - 09/2014
9	Ranibizumab (Lucentis)FDA Link 01/2023 - 09/2013
9	afliberceptIBA 01/2023 - 01/2014
7	Bevacizumab (Avastin)FDA Link 12/2022 - 01/2014
3	Dexamethasone (Maxidex)FDA LinkGeneric 04/2022 - 06/2010
3	salicylhydroxamic acid (SHAM)IBA 01/2019 - 06/2010
2	MicroRNAs (MicroRNA)IBA 01/2016 - 01/2015
2	Fluorescein (Funduscein)FDA LinkGeneric 10/2015 - 03/2013
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Antiglaucoma AgentsIBA 04/2022
1	Serine (L-Serine)FDA Link 10/2019
1	Serine C-PalmitoyltransferaseIBA 10/2019
1	Amino Acids FDA Link 10/2019
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2019
1	resazurinIBA 01/2019
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2019
1	cadherin 5IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Neuroprotective AgentsIBA 01/2019
1	Simvastatin (Zocor)FDA LinkGeneric 01/2019
1	Ciliary Neurotrophic Factor (CNTF)IBA 01/2019
1	IronIBA 01/2017
1	SteroidsIBA 09/2015
1	ArgonIBA 03/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2013
1	Macular PigmentIBA 12/2010
1	Protein Isoforms (Isoforms)IBA 12/2010
1	Glutathione S-Transferase piIBA 12/2010
1	Therapeutic UsesIBA 01/2010
1	Fenofibrate (CiL)FDA LinkGeneric 03/2008

Therapy/Procedure

7	Therapeutics 04/2024 - 09/2014
5	Injections 04/2024 - 12/2011
4	Intravitreal Injections 12/2022 - 01/2022
2	Lasers (Laser) 03/2013 - 05/2012
1	Photochemotherapy (Photodynamic Therapy) 01/2019
1	Light Coagulation 05/2012
1	Drug Therapy (Chemotherapy) 05/2012
1	Scleral Buckling 04/2005